The DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index.
Evaluation and management of heart failure with preserved ejection fraction
Abstract
Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide, in tandem with ageing of the general population and the increasing prevalences of obesity, diabetes mellitus and hypertension. The clinical syndrome of HFpEF is heterogeneous and must be distinguished from heart failure with reduced ejection fraction as well as other aetiologies that have different treatment strategies. The diagnosis of HFpEF is challenging and ultimately relates to the conceptual definition of heart failure as a clinical syndrome characterized by symptoms that are associated with a reduced capacity of the heart to pump blood adequately at normal filling pressures during diastole. Clinical trials to date have been largely unsuccessful in identifying effective treatments for HFpEF but evidence supports the use of diuretics, mineralocorticoid antagonists and lifestyle interventions. Pathophysiological heterogeneity in the presentation of HFpEF is substantial, and ongoing studies are underway to evaluate the optimal methods to classify patients into phenotypically homogeneous subpopulations to facilitate better individualization of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even if the diastolic dysfunction is the hemodynamic feature of HFpEF, the essence of its pathophysiology is the increase of LV filling pressure, meaning that the heart can adequately pump the blood at expense of an elevation of cardiac filling pressures that, if disproportionate during exercise or at rest, are responsible of dyspnea [102,103].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [102]
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,532
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Cited by
Sorted by citations
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306963 · Cited by 1,669
Self-citationSemaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Kosiborod, M. N., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Treppendahl, M. B., Verma, S., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2313917 · Cited by 758
Self-citationHeart Failure With Preserved Ejection Fraction
Borlaug, B. A., Sharma, K., Shah, S. J., & Ho, J. E. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.049 · Cited by 742
Self-citationBorlaug, B. A., Jensen, M. D., Kitzman, D. W., Lam, C. S. P., Obokata, M., & Rider, O. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac120 · Cited by 450
Self-citationReddy, Y. N. V., Obokata, M., Verbrugge, F. H., Lin, G., & Borlaug, B. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.009 · Cited by 413
Self-citationFrom Systemic Inflammation to Myocardial Fibrosis
Paulus, W. J., & Zile, M. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318159 · Cited by 413
Kosiborod, M., Deanfield, J. E., Pratley, R. E., Borlaug, B. A., Butler, J., Davies, M. J., Emerson, S. S., Kahn, S. E., Kitzman, D. W., Lingvay, I., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01643-x · Cited by 331
Self-citationHeart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
Omote, K., Verbrugge, F. H., & Borlaug, B. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-022745 · Cited by 232
Self-citationSarcopenia and cardiovascular diseases: A systematic review and meta‐analysis
Zuo, X., Li, X., Tang, K., Zhao, R., Wu, M., Wang, Y., & Li, T. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13221 · Cited by 221
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Roh, J. D., Hill, J. A., Singh, A. S. C., Valero‐Muñoz, M., & Sam, F. (2022) · Circulation Research · doi:10.1161/circresaha.122.320257 · Cited by 202
Heart failure with preserved ejection fraction
HAMO, C. E., DeJong, C., Hartshorne‐Evans, N., Lund, L. H., Shah, S. J., Solomon, S. D., & Lam, C. S. P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00540-y · Cited by 197
Maconi, G., Parente, F., Bollani, S., Cesana, B. M., & Porro, G. B. (1996) · PubMed · Cited by 177
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
Park, J. J. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0282 · Cited by 186
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea
Reddy, Y. N. V., Kaye, D. M., Handoko, M. L., van de Bovenkamp, A. A., Tedford, R. J., Keck, C., Andersen, M. J., Sharma, K., Trivedi, R. K., Carter, R. E., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.1916 · Cited by 178
Self-citationInflammation in Human Heart Failure: Major Mediators and Therapeutic Targets
Reina‐Couto, M., Pereira‐Terra, P., Quelhas‐Santos, J., Silva-Pereira, C., Albino‐Teixeira, A., & Sousa, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746494 · Cited by 164
Schiattarella, G. G., Altamirano, F. J., Kim, S. Y., Tong, D., Ferdous, A., Piristine, H. C., Dasgupta, S., Wang, X., French, K. M., Villalobos, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21931-9 · Cited by 145
Withaar, C., Lam, C. S. P., Schiattarella, G. G., de Boer, R. A., & Meems, L. M. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab389 · Cited by 150
Pugliese, N. R., Pellicori, P., Filidei, F., Biase, N. D., Maffia, P., Guzik, T. J., Masi, S., Taddei, S., & Cleland, J. G. F. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac133 · Cited by 150
Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction
Alogna, A., Koepp, K. E., Sabbah, M., Espindola Netto, J. M., Jensen, M. D., Kirkland, J. L., Lam, C. S. P., Obokata, M., Petrie, M. C., Ridker, P. M., et al. (2023) · JACC: Heart Failure · doi:10.1016/j.jchf.2023.06.031 · Cited by 142
Self-citationImmunometabolic mechanisms of heart failure with preserved ejection fraction
Schiattarella, G. G., Alcaide, P., Condorelli, G., Gillette, T. G., Heymans, S. R. B., Jones, E. A. V., Kallikourdis, M., Lichtman, A. H., Marelli‐Berg, F. M., Shah, S. J., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00032-w · Cited by 137
Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
Uijl, A., Savarese, G., Vaartjes, I. C. H., Dahlström, U., Brugts, J. J., Linssen, G. C. M., van Empel, V. P. M., Rocca, H. B., Asselbergs, F. W., Lund, L. H., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2169 · Cited by 135
Borlaug, B. A., Blair, J., Bergmann, M. W., Bugger, H., Burkhoff, D., Bruch, L., Celermajer, D. S., Claggett, B. L., Cleland, J. G. F., Cutlip, D. E., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059486 · Cited by 131
Self-citationGuía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
Marcondes‐Braga, F. G., Moura, L. Z., Issa, V. S., Vieira, J. L., Rohde, L. E. P., Simões, M. V., Fernandes-Silva, M. M., Rassi, S., Martins, S. M., de Albuquerque, D. C., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210367 · Cited by 169
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review
Hsu, S., Fang, J. C., & Borlaug, B. A. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.012 · Cited by 111
Self-citationKosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Christensen, L., Davies, M., Hovingh, K. G., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · JACC: Heart Failure · doi:10.1016/j.jchf.2023.05.010 · Cited by 97
Self-citationArtificial Intelligence-Enabled ECG for Left Ventricular Diastolic Function and Filling Pressure
Lee, E., Ito, S., Miranda, W. R., Lopez-Jimenez, F., Kane, G. C., Asirvatham, S. J., Noseworthy, P. A., Friedman, P. A., Carter, R. E., Borlaug, B. A., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-023-00993-7 · Cited by 106
Self-citationBurrage, M. K., Hundertmark, M., Valkovič, L., Watson, W. D., Rayner, J. J., Sabharwal, N. K., Ferreira, V. M., Neubauer, S., Miller, J. J. J. J., Rider, O. J., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054858 · Cited by 102
Zhou, Q., Yang, J., Tang, H., Guo, Z., Dong, W., Wang, Y., Meng, X., Zhang, K., Wang, W., Shao, C., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02001-4 · Cited by 93
Satoh, T., Wang, L., Espinosa‐Díez, C., Wang, B., Hahn, S. A., Noda, K., Rochon, E. R., Dent, M. R., Levine, A. R., Baust, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.053889 · Cited by 87
Performance and Interpretation of Invasive Hemodynamic Exercise Testing
Jain, C. C., & Borlaug, B. A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.552 · Cited by 85
Self-citationPagel, P. S., Tawil, J. N., Boettcher, B. T., Izquierdo, D. A., Lazicki, T. J., Crystal, G. J., & Freed, J. K. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.016 · Cited by 86
Sugumar, H., Nanayakkara, S., Vizi, D., Wright, L. M., Chieng, D., Leet, A. S., Mariani, J. A., Voskoboinik, A., Prabhu, S., Taylor, A. J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2122 · Cited by 84
ACC/AHA/HFSA 2022 and ESC 2021 Guidelines on Heart Failure Comparison
Behnoush, A. H., Khalaji, A., Naderi, N., Ashraf, H., & von Haehling, S. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14255 · Cited by 92
Sex and central obesity in heart failure with preserved ejection fraction
Sorimachi, H., Omote, K., Omar, M., Popović, D., Verbrugge, F. H., Reddy, Y. N. V., Lin, G., Obokata, M., Miles, J. M., Jensen, M. D., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2563 · Cited by 86
Self-citationDachs, T.-M., Duca, F., Rettl, R., Binder, C., Dalos, D., Ligios, L. C., Kammerlander, A. A., Grünig, E., Pretsch, I., Steringer‐Mascherbauer, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac389 · Cited by 84
SIRT3 Deficiency Enhances Ferroptosis and Promotes Cardiac Fibrosis via p53 Acetylation
Su, H., Cantrell, A. C., Chen, J., Gu, W. J., & Zeng, H. (2023) · Cells · doi:10.3390/cells12101428 · Cited by 79
Obokata, M., Sorimachi, H., Harada, T., Kagami, K., Saito, Y., & Ishii, H. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.09.018 · Cited by 83
Reza, N., Gruen, J., & Bozkurt, B. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100093 · Cited by 79
Central Haemodynamic Abnormalities and Outcome in Patients with Unexplained Dyspnoea
Omote, K., Verbrugge, F. H., Sorimachi, H., Omar, M., Popović, D., Obokata, M., Reddy, Y. N. V., & Borlaug, B. A. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2747 · Cited by 74
Self-citationVentricular Stiffening and Chamber Contracture in Heart Failure with Higher Ejection Fraction
Popović, D., Alogna, A., Omar, M., Sorimachi, H., Omote, K., Reddy, Y. N. V., Redfield, M. M., Burkhoff, D., & Borlaug, B. A. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2843 · Cited by 75
Self-citationMa, S., He, L., Zhang, G., Zuo, Q., Wang, Z., Zhai, J., Zhang, T., Wang, Y., Ma, H., & Guo, Y. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02243-1 · Cited by 70
The role of FGF21 in the pathogenesis of cardiovascular disease
Zhang, Y., Liu, D., Long, X.-X., Fang, Q.-C., Jia, W.-P., & Li, H.-T. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001890 · Cited by 68
Buono, M. G. D., Iannaccone, G., Scacciavillani, R., Carbone, S., Camilli, M., Niccoli, G., Borlaug, B. A., Lavie, C. J., Arena, R. A., Crea, F., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.011 · Cited by 70
Self-citationGopalasingam, N., Hansen, K. B., Christensen, K. H., Ladefoged, B. T., Poulsen, S. H., Andersen, M. J., Borlaug, B. A., Nielsen, R. R., Møller, N., & Wiggers, H. (2024) · Circulation · doi:10.1161/circulationaha.124.069732 · Cited by 70
Self-citationCOHEN, L. P., Isaza, N., Hernandez, I., Lewis, G. D., Ho, J. E., Fonarow, G. C., Kazi, D. S., & Bellows, B. K. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.0077 · Cited by 65
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62
Wang, J., Chen, P., Cao, Q., Wang, W., & Chang, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9205908 · Cited by 62
Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice
Ranjbarvaziri, S., Zeng, A., Wu, I., Greer-Short, A., Farshidfar, F., Budan, A., Xu, E., Shenwai, R., Kozubov, M., Li, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45440-7 · Cited by 62
Aslam, M., Hahn, V. S., Jani, V., Hsu, S., Sharma, K., & Kass, D. A. (2020) · Circulation · doi:10.1161/circulationaha.120.052414 · Cited by 60
Rosalia, L., Öztürk, Ç., Shoar, S., Fan, Y., Malone, G., Cheema, F. H., Conway, C., Byrne, R. A., Duffy, G. P., Malone, A. J., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.002 · Cited by 56
Harada, T., Kagami, K., Shina, T., Sorimachi, H., Yuasa, N., Saito, Y., Naito, A., Yoshida, K., Kato, T., Wada, N., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2862 · Cited by 55
Huang, R., Lin, Y., Liu, M., Xiong, Z., Zhang, S., Zhong, X., Ye, X., Huang, Y., Zhuang, X., & Liao, X. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022765 · Cited by 55
Mechano-energetic uncoupling in heart failure
Aksentijević, D., Sedej, S., Fauconnier, J., Paillard, M., Abdellatif, M., Streckfuß‐Bömeke, K., Ventura‐Clapier, R., van der Velden, J., de Boer, R. A., Bertero, E., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01167-6 · Cited by 55
PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling
Oppedisano, F., Mollace, R., Tavernese, A., Gliozzi, M., Musolino, V., Macrì, R., Carresi, C., Maiuolo, J., Serra, M. D. R., Cardamone, A., et al. (2021) · Nutrients · doi:10.3390/nu13092965 · Cited by 54
Sex Differences and Regulatory Actions of Estrogen in Cardiovascular System
Ueda, K., Fukuma, N., Adachi, Y., Numata, G., Tokiwa, H., Toyoda, M., Otani, A., Hashimoto, M., Liu, P., & Takimoto, E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.738218 · Cited by 57
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
Budde, H., Hassoun, R., Mügge, A., Kov́acs, Á., & Hamdani, N. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.928232 · Cited by 56
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment
Youn, J., Kim, D., Cho, J. Y., Cho, D., Park, S. M., Jung, M., Hyun, J., Cho, H., Park, S., Choi, J., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0011 · Cited by 53
Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications
Naser, J. A., Lee, E., Scott, C. G., Kennedy, A. M., Pellikka, P. A., Lin, G., Pislaru, S. V., & Borlaug, B. A. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad592 · Cited by 53
Self-citationAriyaratnam, J., Elliott, A. D., Mishima, R. S., Gallagher, C., Lau, D. H., & Sanders, P. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.09.015 · Cited by 52
Bilak, J. M., Alam, U., Miller, C., McCann, G. P., Arnold, J. R., & Kanagala, P. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.12 · Cited by 50
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction
Litwin, S. E., Komtebedde, J., Hu, M., Burkhoff, D., Hasenfuss, G. P., Borlaug, B. A., Solomon, S. D., Zile, M. R., Mohan, R. C., Khawash, R., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.01.030 · Cited by 51
Self-citationHarada, T., Obokata, M., Kagami, K., Sorimachi, H., Kato, T., Takama, N., Wada, N., & Ishii, H. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.10.024 · Cited by 48
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 58
Amanai, S., Harada, T., Kagami, K., Yoshida, K., Kato, T., Wada, N., & Obokata, M. (2022) · Scientific Reports · doi:10.1038/s41598-021-03974-6 · Cited by 51
Stoicescu, L., Crișan, D., Morgovan, C., Avram, L., & Ghibu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020794 · Cited by 57
Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF
Luo, L., Zuo, Y., & Dai, L. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02707-7 · Cited by 54
Verbrugge, F. H., Reddy, Y. N. V., Sorimachi, H., Omote, K., Carter, R. E., & Borlaug, B. A. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2142 · Cited by 49
Self-citationFibroblast growth factor 21 in heart failure
Tucker, W., Tucker, B., Rye, K., & Ong, K. L. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10268-0 · Cited by 44
Schauer, A., Adams, V., Kämmerer, S., Langner, E., Augstein, A., Barthel, P., Männel, A., Fabig, G., Alves, P. K. N., Günscht, M., et al. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011107 · Cited by 44
Moura, B., Aimo, A., Al‐Mohammad, A., Flammer, A. J., Barberis, V. I., Bayés‐Genís, A., Rocca, H. B., Fontes‐Carvalho, R., Grapsa, J., Hülsmann, M., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2339 · Cited by 44
Li, G., Zhao, H., Cheng, Z., Liu, J., Li, G., & Guo, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.006 · Cited by 46
Zhao, X., Sui, Y., Ruan, X., Wang, X., He, K., Dong, W., Qu, H., & Fang, X. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01232-8 · Cited by 41
Ottosen, C. I., Nadruz, W., Inciardi, R. M., Johansen, N. D., Fudim, M., & Biering‐Sørensen, T. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae178 · Cited by 45
Rosalia, L., Öztürk, Ç., Coll‐Font, J., Fan, Y., Nagata, Y., Singh, M., Goswami, D., Mauskapf, A., Chen, S., Eder, R. A., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00937-8 · Cited by 40
Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction
Xiang, B., Zhang, R., Wu, X., & Zhou, X. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31963 · Cited by 45
Kumar, H. U., Nearing, B. D., Mittal, S., Premchand, R. K., Libbus, I., DiCarlo, L. A., Amurthur, B., KenKnight, B. H., Anand, I. S., & Verrier, R. L. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.03.030 · Cited by 41
Harada, T., Kagami, K., Kato, T., & Obokata, M. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.11.003 · Cited by 45
Bai, B., Cheng, M., Jiang, L., Xu, J., Chen, H., & Xu, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.614757 · Cited by 43
Saito, Y., Obokata, M., Harada, T., Kagami, K., Wada, N., Okumura, Y., & Ishii, H. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad127 · Cited by 40
Ariyaratnam, J., Elliott, A. D., Mishima, R. S., Kadhim, K., McNamee, O., Kuklik, P., Emami, M., Malik, V., Fitzgerald, J. L., Gallagher, C., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.07.019 · Cited by 39
Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction
Inampudi, C., Silverman, D. N., Simon, M. A. M., Leary, P. J., Sharma, K., Houston, B. A., Vachiéry, J., Haddad, F., & Tedford, R. J. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.039 · Cited by 38
Meijs, C. M. E. M., Handoko, M. L., Savarese, G., Vernooij, R. W. M., Vaartjes, I. C. H., Banerjee, A., Koudstaal, S., Brugts, J. J., Asselbergs, F. W., & Uijl, A. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00615-z · Cited by 40
Cheng, X., Zhao, H., Wen, X., Li, G., Guo, S., & Zhang, D. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122185 · Cited by 37
The pig as an optimal animal model for cardiovascular research
Jia, H., Chang, Y., & Song, J. (2024) · Lab Animal · doi:10.1038/s41684-024-01377-4 · Cited by 39
Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., & Patel, R. K. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac146 · Cited by 40
Banerjee, M., Pal, R., Nair, K., & Mukhopadhyay, S. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.03.003 · Cited by 41
Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure
Molinsky, R. L., yuzefpolskaya, M., Norby, F. L., Yu, B., Shah, A. M., Pankow, J. S., Ndumele, C. E., Lutsey, P. L., Papapanou, P. N., Beck, J. D., et al. (2022) · JACC Heart Failure · doi:10.1016/j.jchf.2022.05.008 · Cited by 35
Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice
Xiong, Y., Liu, X., Jiang, L., Hao, T., Wang, Y., & Li, T. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04734-y · Cited by 35
Ni, W., Jiang, R., Xu, D., Zhu, J., Chen, J., Lin, Y., & Zhou, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02595-x · Cited by 35
van Wezenbeek, J., Kianzad, A., van de Bovenkamp, A. A., Wessels, J. N., Mouratoglou, S., Braams, N. J., Jansen, S. M. A., Meulblok, E., Meijboom, L. J., Marcus, J. T., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008726 · Cited by 35
The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload
Pakhomov, N. V., & Baugh, J. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00573.2020 · Cited by 34
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction
Gentile, F., Ghionzoli, N., Borrelli, C., Vergaro, G., Pastore, M. C., Cameli, M., Emdin, M., Passino, C., & Giannoni, A. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab077 · Cited by 35
The Gut in Heart Failure: Current Knowledge and Novel Frontiers
Gallo, A., Macerola, N., Favuzzi, A. M. R., Nicolazzi, M. A., Gasbarrini, A., & Montalto, M. (2022) · Medical Principles and Practice · doi:10.1159/000522284 · Cited by 36
Abudureyimu, M., Yang, M., Wang, X., Luo, X., Ge, J., Hu, P., Zhang, Y., & Ren, J. T. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0983-0 · Cited by 33
Jain, C. C., Tschirren, J., Reddy, Y. N. V., Melenovský, V., Redfield, M. M., & Borlaug, B. A. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.09.017 · Cited by 33
Self-citationThe future of heart failure with preserved ejection fraction
Heinzel, F. R., & Shah, S. J. (2022) · Herz · doi:10.1007/s00059-022-05124-8 · Cited by 36
Metadata
- Authors
- Borlaug, B. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Borlaug, Barry A.
- ORCID
- Borlaug, Barry A.
- Venue
- Nature Reviews Cardiology
- Published
- 2020-03-30
- Volume
- 17
- Issue
- 9
- Pages
- 559-573
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W3013711965
- Cited by
- 675
- References
- 180
- Citations by year
- 2026: 97 · 2025: 104 · 2024: 130 · 2023: 132 · 2022: 120 · 2021: 71 · 2020: 19
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL128526, U01HL125205)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- heart failure with preserved ejection fraction, HFpEF diagnosis, diuretics, mineralocorticoid receptor antagonists, lifestyle intervention, phenotypic subgroups, personalized treatment, diastolic dysfunction, aging, obesity, diabetes mellitus, hypertension
- MeSH terms
- Heart Failure, Humans, Middle Aged, Stroke Volume
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
